Workflow
Golden Cross
icon
Search documents
Should You Buy Sensata (ST) After Golden Cross?
ZACKS· 2025-07-17 14:56
Group 1 - Sensata Technologies Holding N.V. (ST) has reached a key level of support and is showing potential for a bullish breakout due to a "golden cross" formation, where the 50-day simple moving average has crossed above the 200-day simple moving average [1] - The golden cross indicates a positive trend reversal after a downtrend, suggesting that ST could continue to gain momentum towards higher prices [2] - ST's shares have increased by 9.8% over the past four weeks, and the company holds a 2 (Buy) rating on the Zacks Rank, indicating strong potential for further gains [3] Group 2 - There has been a positive shift in ST's earnings expectations, with one upward revision and no downward changes in the last 60 days, leading to an increase in the Zacks Consensus Estimate [3] - The combination of favorable earnings estimate revisions and the technical breakout signals suggests that investors should monitor ST for potential gains in the near future [4]
X @Crypto Rover
Crypto Rover· 2025-07-17 14:42
GOLDEN CROSS FOR ALTCOINS! 🚀Last time this happend we pumped 72%... https://t.co/Xh2htw74Ag ...
X @Decrypt
Decrypt· 2025-07-16 20:04
Ethereum Forms 'Golden Cross', With Bulls in Control: Analysis► https://t.co/qU1umu8xLB https://t.co/qU1umu8xLB ...
X @Litecoin
Litecoin· 2025-07-15 18:33
Is that good?Tony "The Bull" Severino, CMT (@TonyTheBullCMT):Litecoin LTCUSD has Golden Crossed on the weekly https://t.co/Uh4f5ozuG7 ...
Here's How to Play AbbVie Stock as it Reaches Golden Cross
ZACKS· 2025-07-15 13:36
Core Insights - AbbVie's stock has achieved a "golden cross," indicating bullish momentum and potential for prolonged upward trends [1][9] - The company has successfully launched new drugs, Skyrizi and Rinvoq, to offset the decline in sales from Humira due to patent loss [4][5] - AbbVie expects significant revenue growth driven by these new products and a strong pipeline [25][26] Group 1: Stock Performance - AbbVie's stock has been trading above its 50-day and 200-day simple moving averages since early July, signaling positive momentum [1] - The stock has gained 9.8% year-to-date, outperforming the industry and the S&P 500 index [16][18] Group 2: Product Performance - Skyrizi and Rinvoq generated combined sales of $5.1 billion in Q1 2025, reflecting over 65% growth year-over-year [6][9] - AbbVie anticipates combined sales of Skyrizi and Rinvoq to reach approximately $24.7 billion in 2025 and over $31 billion by 2027 [7] Group 3: Pipeline and Acquisitions - AbbVie has a diverse pipeline with several early/mid-stage candidates, including promising therapies for blood cancers and solid tumors [10][11] - The company has been active in acquisitions, including the recent purchase of Capstan Therapeutics for nearly $2.1 billion, enhancing its immunology pipeline [12][13] Group 4: Challenges and Market Conditions - Humira's sales have declined by almost 50% in Q1 2025 due to biosimilar competition [14] - Sales of Juvederm fillers have also decreased by 10.2% in Q1 2025, impacted by challenging market conditions in the U.S. and China [15] Group 5: Future Outlook - AbbVie expects to return to robust mid-single-digit revenue growth in 2025, driven by the performance of Skyrizi and Rinvoq [25] - The company is well-positioned for continued strong growth, with no significant loss of exclusivity events anticipated for the rest of the decade [25][26]
Old National Bancorp (ONB)'s Technical Outlook is Bright After Key Golden Cross
ZACKS· 2025-07-14 14:55
Core Viewpoint - Old National Bancorp (ONB) has reached a significant support level and is considered a good investment opportunity from a technical perspective due to the recent "golden cross" formation in its moving averages [1]. Technical Analysis - ONB's 50-day simple moving average has recently broken above its 200-day moving average, indicating a bullish breakout [1]. - A golden cross is characterized by a downtrend that bottoms out, followed by the shorter moving average crossing above the longer moving average, leading to an upward price momentum [2]. Performance Metrics - Over the past four weeks, ONB has gained 13.4%, suggesting positive momentum [3]. - The stock currently holds a 2 (Buy) rating on the Zacks Rank, indicating potential for further breakout [3]. - Earnings expectations for ONB have improved, with two upward revisions and no downward changes in estimates over the past 60 days, further supporting the bullish outlook [3]. Investment Consideration - Given the technical indicators and positive earnings estimate movements, investors are encouraged to consider adding ONB to their watchlist [5].
X @Ash Crypto
Ash Crypto· 2025-07-13 09:28
ALTCOIN MCAP GOLDEN CROSS IS ABOUT TO HAPPEN.Last time this happened in Q4 2024 and Crypto MCap pumped 41% in just 2 weeks.Altseason is coming 🚀 https://t.co/gVNzBmbiZW ...
JBT Marel (JBTM) Just Flashed Golden Cross Signal: Do You Buy?
ZACKS· 2025-07-11 14:56
Technical Analysis - JBT Marel Corporation (JBTM) has reached a key level of support, indicated by a "golden cross" where the 50-day simple moving average has crossed above the 200-day simple moving average [1][2] - A golden cross is a bullish chart pattern that suggests a potential breakout, typically involving the 50-day and 200-day moving averages [2] Market Performance - Over the past four weeks, JBTM has gained 11.3%, indicating positive momentum in the stock [4] - The company currently holds a 2 (Buy) rating on the Zacks Rank, suggesting it may be poised for further breakout [4] Earnings Outlook - JBTM has a positive earnings outlook for the current quarter, with one upward revision in earnings estimates over the past 60 days and no downward revisions [4] - The Zacks Consensus Estimate for JBTM has also increased, reinforcing the bullish sentiment around the stock [4][5]
After Golden Cross, GMS (GMS)'s Technical Outlook is Bright
ZACKS· 2025-07-11 14:56
Core Viewpoint - GMS Inc. (GMS) is identified as a potential stock pick due to a recent "golden cross" event, indicating a bullish trend from a technical perspective [1][4]. Technical Analysis - A "golden cross" occurs when a short-term moving average (50-day) crosses above a long-term moving average (200-day), suggesting a potential bullish breakout [2]. - The formation of a golden cross involves three stages: a downtrend that bottoms out, the crossover of moving averages, and continued upward momentum [3]. Performance Metrics - GMS has experienced a significant rally of 40.6% over the past four weeks, indicating strong price movement [4]. - The company currently holds a 2 (Buy) rating on the Zacks Rank, suggesting positive market sentiment [4]. Earnings Outlook - The earnings outlook for GMS is positive, with no downward revisions in earnings estimates over the past two months and three upward revisions, leading to an increase in the Zacks Consensus Estimate [4]. - This positive earnings outlook further strengthens the bullish case for GMS [4]. Investment Consideration - Investors are encouraged to consider adding GMS to their watchlist due to the important technical indicators and the positive movement in earnings estimates [5].
Shore Bancshares (SHBI) Just Flashed Golden Cross Signal: Do You Buy?
ZACKS· 2025-07-10 14:57
Core Viewpoint - Shore Bancshares Inc (SHBI) is showing potential for a bullish breakout due to a recent "golden cross" in its moving averages, indicating a key level of support and positive technical signals [1]. Technical Analysis - SHBI's 50-day simple moving average has crossed above its 200-day simple moving average, forming a "golden cross," which is a significant bullish indicator [1]. - The golden cross pattern typically involves three stages: a downtrend followed by a crossover of the shorter moving average over the longer one, and finally, an upward price movement [2]. Performance Metrics - Over the past four weeks, SHBI shares have increased by 10% [3]. - The company currently holds a 1 (Strong Buy) rating on the Zacks Rank, suggesting strong potential for further gains [3]. Earnings Outlook - There has been one upward revision in earnings estimates for SHBI in the last 60 days, with no downward revisions, indicating a positive earnings outlook for the current quarter [3]. - The Zacks Consensus Estimate for SHBI has also increased, reinforcing the bullish sentiment around the stock [4].